{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-069668","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2025-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.637769+00:00","generated_at":"2026-05-24T00:58:42.129232+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Climb Bio announces board changes: two directors depart, two new directors elected","bullets":["Simon Tate resigned as director on March 27, 2025, also leaving audit and nominating committees; no disagreement.","Adam Rosenberg will not seek re-election at 2025 annual meeting; no disagreement with company.","Board expanded from 7 to 8; Alexander (Bo) Cumbo and Kimberlee Drapkin elected effective March 28, 2025.","Cumbo to chair compensation committee; Drapkin to chair audit committee.","Each new director received option to purchase 80,000 shares at $1.28/share, vesting over three years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-069668","json":"https://secwatch.observer/filing/0001193125-25-069668.json","markdown":"https://secwatch.observer/filing/0001193125-25-069668.md","text":"https://secwatch.observer/filing/0001193125-25-069668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/0001193125-25-069668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/d853219d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T00:58:42.129232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"629a93a643","claim":"Simon Tate resigned as member of the board of directors at Climb Bio, Inc..","evidence_excerpt":"Simon Tate notified Climb Bio, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/0001193125-25-069668-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"},{"claim_id":"7cef58e6ef","claim":"Alexander (Bo) Cumbo was elected as member of the board of directors at Climb Bio, Inc..","evidence_excerpt":"Mr. Cumbo was elected to serve with a term expiring at the Company’s 2026 annual meeting of stockholders and thereafter until his successor has been duly appointed and qualified or until his earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/0001193125-25-069668-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"},{"claim_id":"ac7acce501","claim":"Kimberlee (Kim) Drapkin was elected as member of the board of directors at Climb Bio, Inc..","evidence_excerpt":"Ms. Drapkin was elected to serve with a term expiring at the Company’s 2027 annual meeting of stockholders and thereafter until her successor has been duly appointed and qualified or until her earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/0001193125-25-069668-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"},{"claim_id":"d5cceec956","claim":"Adam Rosenberg departed as member of the board of directors at Climb Bio, Inc..","evidence_excerpt":"Adam Rosenberg notified the Company that he does not intend to seek re-election as a member of the Board when his current term ends at the Company’s 2025 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525069668/0001193125-25-069668-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"does not intend to seek re-election"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}